Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe hemolytic anemia following high-dose intravenous immunoglobulin administration in a patient with Kawasaki disease.

Literature DB >> 10679809

Severe hemolytic anemia following high-dose intravenous immunoglobulin administration in a patient with Kawasaki disease.

M Nakagawa, N Watanabe, M Okuno, M Kondo, H Okagawa, T Taga.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2000 PMID： 10679809 DOI： 10.1002/(sici)1096-8652(200003)63:3<160::aid-ajh11>3.0.co;2-4

Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

Review 1. Intravenous immunoglobulin: adverse effects and safe administration.

Authors: Hedi Orbach; Uriel Katz; Yaniv Sherer; Yehuda Shoenfeld
Journal: Clin Rev Allergy Immunol Date: 2005-12 Impact factor: 8.667

Review 2. RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME).

Authors: Jenny M Despotovic; Michele P Lambert; Jay H Herman; Terry B Gernsheimer; Keith R McCrae; Michael D Tarantino; James B Bussel
Journal: Transfusion Date: 2011-10-07 Impact factor: 3.157

3. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.

Authors: Ho-Chang Kuo; Ya-Ling Yang; Jiin-Haur Chuang; Mao-Meng Tiao; Hong-Ren Yu; Li-Tung Huang; Kuender D Yang; Wei-Chiao Chang; Chiu-Ping Lee; Ying-Hsien Huang
Journal: J Clin Immunol Date: 2012-03-06 Impact factor: 8.317

Review 4. Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders.

Authors: Andreas Steinbrecher; Peter Berlit
Journal: J Neurol Date: 2006-09 Impact factor: 4.849

5. Changes in Hemoglobin Concentrations Post-immunoglobulin Therapy in Patients with Kawasaki Disease: A Population-Based Study Using a Claims Database in Japan.

Authors: Masato Takeuchi; Shuichi Ito; Masaki Nakamura; Koji Kawakami
Journal: Paediatr Drugs Date: 2018-12 Impact factor: 3.022

6. Co-morbidity of Kawasaki disease.

Authors: Fang-Liang Huang; Te-Kau Chang; Sheng-Ling Jan; Chi-Ren Tsai; Li-Chung Wang; Mei-Chin Lai; Po-Yen Chen
Journal: Indian J Pediatr Date: 2011-11-05 Impact factor: 5.319

7. Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases.

Authors: Roberta Berard; Blair Whittemore; Rosie Scuccimarri
Journal: Pediatr Rheumatol Online J Date: 2012-04-16 Impact factor: 3.054